Sachel Mok

About Sachel Mok

Sachel Mok, With an exceptional h-index of 28 and a recent h-index of 26 (since 2020), a distinguished researcher at Columbia University in the City of New York, specializes in the field of malaria.

His recent articles reflect a diverse array of research interests and contributions to the field:

Determinants of piperaquine-resistant malaria in South America

Mapping the genomic landscape of multidrug resistance in Plasmodium falciparum and its impact on parasite fitness

Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum

Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation

Short tandem repeat polymorphism in the promoter region of cyclophilin 19B drives its transcriptional upregulation and contributes to drug resistance in the malaria parasite …

Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials

Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual …

Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending …

Sachel Mok Information

University

Position

Columbia University Medical Center

Citations(all)

4135

Citations(since 2020)

2510

Cited By

2536

hIndex(all)

28

hIndex(since 2020)

26

i10Index(all)

42

i10Index(since 2020)

39

Email

University Profile Page

Google Scholar

Sachel Mok Skills & Research Interests

malaria

Top articles of Sachel Mok

Determinants of piperaquine-resistant malaria in South America

The Lancet Infectious Diseases

2024/2/1

Sachel Mok
Sachel Mok

H-Index: 20

Mapping the genomic landscape of multidrug resistance in Plasmodium falciparum and its impact on parasite fitness

Science Advances

2023/11/8

Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum

Nature Communications

2023/5/27

Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation

Nature Communications

2023/3/16

Short tandem repeat polymorphism in the promoter region of cyclophilin 19B drives its transcriptional upregulation and contributes to drug resistance in the malaria parasite …

PLoS pathogens

2023/1/25

Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials

The Journal of Infectious Diseases

2022/12/1

Sachel Mok
Sachel Mok

H-Index: 20

Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual …

PLoS pathogens

2022/10/28

Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending …

The Lancet Infectious Diseases

2022/6/1

The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance

Cell chemical biology

2022/5/19

Comparative analysis of Plasmodium falciparum genotyping via SNP detection, microsatellite profiling, and whole-genome sequencing

Antimicrobial Agents and Chemotherapy

2022/1/18

Tomas Yeo
Tomas Yeo

H-Index: 6

Sachel Mok
Sachel Mok

H-Index: 20

Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series

Journal of medicinal chemistry

2021/4/20

3-Hydroxy-propanamidines, a new class of orally active antimalarials targeting Plasmodium falciparum

Journal of medicinal chemistry

2021/3/5

Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in Plasmodium falciparum

Journal of medicinal chemistry

2021/2/23

Identification and profiling of a novel diazaspiro [3.4] octane chemical series active against multiple stages of the human malaria parasite plasmodium falciparum and …

Journal of medicinal chemistry

2021/2/12

P. falciparum K13 mutations present varying degrees of artemisinin resistance and reduced fitness in African parasites

bioRxiv

2021/1/30

Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites

Scientific reports

2021/1/22

Artemisinin-resistant K13 mutations rewire Plasmodium falciparum’s intra-erythrocytic metabolic program to enhance survival

Nature communications

2021/1/22

The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance

Science translational medicine

2021/7/21

Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness

Elife

2021/7/19

Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors

ACS Infectious Diseases

2021/4/30

See List of Professors in Sachel Mok University(Columbia University in the City of New York)